Steve Lee

High Impact

Researcher

University of Arkansas for Medical Sciences

faculty

35 h-index 192 pubs 4,945 cited

Research Areas

Cancer-related molecular mechanisms research Epigenetics and DNA Methylation Oral Cancer Studies Genomics and Phylogenetic Studies Cancer Genomics and Diagnostics Artificial intelligence-based medical research Molecular Biology Techniques and Applications Microbial infections and disease research

Links

ORCID Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Steve Lee's research focuses on understanding and improving outcomes in various medical conditions, with a significant emphasis on cancer biology and treatment. His work has explored the phenotypic features, underlying biology, and potential therapeutic targets for thyroid carcinoma. He has investigated epigenetic and clinicopathologic predictors of survival in early-stage oral squamous cell carcinoma, developing scores like the REASON score to stratify patient risk. Lee's research also delves into the molecular mechanisms driving cancer progression, including the role of neurotrophin pathway receptors in perineural invasion, metastasis, and pain in oral cancer.

Beyond cancer, Lee has contributed to research on diagnostic and management applications of artificial intelligence, specifically in otolaryngology clinical scenarios. His scholarly output includes studies on noninvasive methods for epigenomic profiling in oral cancer and the use of AI in analyzing tobacco use signatures. He also has a publication on the molecular monitoring of Equine herpesvirus-1 in horses, indicating a breadth of research interests that extends to animal health.

With a substantial publication record (192 publications) and a high citation count (4,945), Lee is recognized as a highly cited researcher. He leads a research group at the University of Arkansas for Medical Sciences, indicating ongoing research activities and mentorship.

Metrics

h-index: 35
Publications: 192
Citations: 4,945

Selected Publications

479MO Erlotinib plus bevacizumab in patients with metastatic solid tumors with EGFR amplification: Results from the KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced solid tumors, KCSG AL 22-09) (2024) DOI
PER- AND POLYFLUOROALKYL SUBSTANCES: AN ATYPICAL RISK FACTOR IN CAD (2024) DOI
Tumor Cell Stemness and Stromal Cell Features Contribute to Oral Cancer Outcome Disparity in Black Americans (2024) DOI
Number of sinus procedures reduces inpatient mortality for invasive fungal rhinosinusitis (2024) DOI
Patient Satisfaction with Nonopioid Postoperative Analgesia in Head and Neck Surgery: A Prospective Randomized Trial (2024) DOI
Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinoma (2024) DOI
Abstract 3772: Tissue-niche-based and cell-type-selective in-depth proteomics (2024) DOI
Data from Evaluation of the 8q24 Prostate Cancer Risk Locus and <i>MYC</i> Expression (2023) DOI
PB1309 Switching from Factor VIIa to Emicizumab in Patients with Hemophilia A and Inhibitor (HAI) in Korea (2023) DOI
Intraneural ganglion cyst of the peroneal nerve at the lateral knee: A case report and literature review (2023) DOI
Diagnostic and Management Applications of ChatGPT in Structured Otolaryngology Clinical Scenarios (2023) DOI
PO-1174 Clinical outcomes of ipsilateral versus bilateral neck irradiation for unilateral tonsillar cancer (2023) DOI
Transoral Laser Resection of the Tongue Base in the Workup of Unknown Primary Head and Neck Squamous Cell Carcinoma (2023) DOI
Supplementary Figure 1 from Evaluation of the 8q24 Prostate Cancer Risk Locus and <i>MYC</i> Expression (2023) DOI
Data from Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen–Specific T-cell Immunity in Head and Neck Cancer Patients (2023) DOI